Truist lowered the firm’s price target on Rapid7 (RPD) to $18 from $22 and keeps a Hold rating on the shares. The company reported Q3 results ahead of guidance on revenue and operating income, with ARR coming in below consensus, the analyst tells investors in a research note. Rapid7’s D&R is growing mid-teens, but with Exposure Management under pressure and macro uncertainty, the firm remains on the sidelines, Truist added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RPD:
